By Lauraann Wood ( September 10, 2018, 10:29 PM EDT) -- AbbVie Inc., the last remaining company to face claims that it failed to warn patients about the hidden dangers of testosterone replacement therapy products, has reached a tentative deal to exit the multidistrict litigation, according to a Monday filing in Illinois federal court....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.